Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO7715 | Sophora tonkinensis | Species | Fabaceae | Eukaryota | Rhizomes | Nanning, Guangxi Province, China | 2012-DEC |
PMID[26132528] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | TM-MC* | |||
NPO7715 | Sophora tonkinensis | Species | Fabaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Activity | = | 39.7 | % | 16364643 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Activity | = | 35.3 | % | 16364643 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Activity | = | 17.1 | % | 16364643 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Activity | = | 15.8 | % | 16364643 |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | >= | 25 | % | 16364643 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | EC50 | = | 31 | ug/ml | 20176893 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Inhibition | = | 43 | % | 20176893 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Activity | = | 60 | % | 20176893 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Inhibition | = | 62 | % | 20176893 |
NPT2 | Others | Unspecified | Inhibition | = | 50 | % | 20176893 | |
NPT2 | Others | Unspecified | Activity | = | 50 | % | 20176893 | |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 100 | 20176893 | ||
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Inhibition | = | 75 | % | 20176893 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Activity | = | 54 | % | 20176893 |
NPT2 | Others | Unspecified | Inhibition | = | 55 | % | 21218816 | |
NPT2 | Others | Unspecified | Inhibition | = | 52 | % | 21757347 | |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | Activity | = | 56 | % | 21757347 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 1852.6 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2818.4 | nM | PubChem BioAssay data set | ||
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 5011.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 21117.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 0.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10583.9 | nM | PubChem BioAssay data set | ||
NPT1453 | Organism | Influenza A virus (A/PR/8/34(H1N1)) | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | EC50 | > | 80000 | nM | 25147619 |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | CC50 | > | 80000 | nM | 25147619 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC80447 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9275 | High Similarity | NPC206241 |
0.9275 | High Similarity | NPC68043 |
0.9275 | High Similarity | NPC180401 |
0.9275 | High Similarity | NPC266383 |
0.9275 | High Similarity | NPC290231 |
0.9275 | High Similarity | NPC271803 |
0.9275 | High Similarity | NPC48448 |
0.8025 | Intermediate Similarity | NPC124359 |
0.7647 | Intermediate Similarity | NPC168017 |
0.7471 | Intermediate Similarity | NPC178632 |
0.7108 | Intermediate Similarity | NPC268580 |
0.6957 | Remote Similarity | NPC243635 |
0.6957 | Remote Similarity | NPC151004 |
0.6957 | Remote Similarity | NPC228980 |
0.6897 | Remote Similarity | NPC207048 |
0.6667 | Remote Similarity | NPC308050 |
0.6477 | Remote Similarity | NPC255430 |
0.6322 | Remote Similarity | NPC120699 |
0.6322 | Remote Similarity | NPC127430 |
0.6064 | Remote Similarity | NPC237535 |
0.5978 | Remote Similarity | NPC143344 |
0.5978 | Remote Similarity | NPC78058 |
0.5978 | Remote Similarity | NPC234822 |
0.5978 | Remote Similarity | NPC61321 |
0.5978 | Remote Similarity | NPC135639 |
0.589 | Remote Similarity | NPC248956 |
0.5806 | Remote Similarity | NPC57163 |
0.5806 | Remote Similarity | NPC116881 |
0.5765 | Remote Similarity | NPC255050 |
0.5765 | Remote Similarity | NPC127553 |
0.5714 | Remote Similarity | NPC145707 |
0.5667 | Remote Similarity | NPC39308 |
0.566 | Remote Similarity | NPC472856 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC80447 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6957 | Remote Similarity | NPD1822 | Approved |
0.6957 | Remote Similarity | NPD1823 | Approved |
0.6957 | Remote Similarity | NPD1821 | Approved |
0.6322 | Remote Similarity | NPD7155 | Clinical (unspecified phase) |
0.6196 | Remote Similarity | NPD3176 | Clinical (unspecified phase) |
0.5938 | Remote Similarity | NPD6934 | Discontinued |
0.5714 | Remote Similarity | NPD3155 | Clinical (unspecified phase) |
0.5658 | Remote Similarity | NPD3727 | Discontinued |
0.5641 | Remote Similarity | NPD605 | Clinical (unspecified phase) |
PubChem CID   | 114850 |
ChEMBL   | CHEMBL458337 |
ZINC   |
Molecular Weight:   | 264.18 |
ALogP:   | |
MLogP:   | 2.67 |
XLogP:   | |
# Rotatable Bonds:   | 0 |
Polar Surface Area:   | 37.38 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 0 |
# Rings:   | 4 |
# Heavy Atoms:   | 19 |